Literature DB >> 15563978

Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes.

Mitsuo Fukushima1, Haruhiko Suzuki, Yutaka Seino.   

Abstract

We have examined the contribution of insulin secretion and insulin resistance to glucose intolerance in Japanese. Some indices of insulin secretion and insulin sensitivity based on the results of OGTT were used. The decline of insulin secretion capacity was significant throughout the development of glucose intolerance from NGT via IGT to DM. Decreased insulinogenic indices were conspicuous when it is compared with other types of diabetes. Slight impairment of insulin secretion has begun in subjects with NGT. The progression from NGT via isolated IGT to isolated post-challenge hyperglycemia was considered mostly due to the deterioration of early-phase insulin secretion. It is summarized that decreased insulin secretion capacity takes a definite role in the development from NGT to type 2 diabetes in Japan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563978     DOI: 10.1016/j.diabres.2003.11.024

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  110 in total

1.  Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels.

Authors:  Jian-Bin Su; Tong Chen; Feng Xu; Xue-Qin Wang; Jin-Feng Chen; Gang Wu; Yan Jin; Xiao-Hua Wang
Journal:  Endocrine       Date:  2013-09-13       Impact factor: 3.633

2.  Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals.

Authors:  Xiao Yun Bao; Bin Peng; Mao Sheng Yang
Journal:  Mol Biol Rep       Date:  2011-06-05       Impact factor: 2.316

Review 3.  New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy.

Authors:  Mitsuyoshi Namba; Tomoyuki Katsuno; Yoshiki Kusunoki; Toshihiro Matsuo; Masayuki Miuchi; Jun-ichiro Miyagawa
Journal:  Clin Exp Nephrol       Date:  2012-11-08       Impact factor: 2.801

4.  Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.

Authors:  Yong-Ho Lee; Eun Seok Kang; So Hun Kim; Seung Jin Han; Chul Hoon Kim; Hyeong Jin Kim; Chul Woo Ahn; Bong Soo Cha; Moonsuk Nam; Chung Mo Nam; Hyun Chul Lee
Journal:  J Hum Genet       Date:  2008-11-11       Impact factor: 3.172

5.  Major dietary patterns, ethnicity, and prevalence of type 2 diabetes in rural Hawaii.

Authors:  Hee-Seon Kim; Song-Yi Park; Andrew Grandinetti; Peter S Holck; Carol Waslien
Journal:  Nutrition       Date:  2008-06-30       Impact factor: 4.008

6.  Effects of a sitagliptin safety alert on prescription behaviour for oral antihyperglycaemic drugs: a propensity score-matched cohort study of prescription receipt data in Japan.

Authors:  Daisaku Sato; Yasunori Sato; Sachiko Masuda; Hiromichi Kimura
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

7.  Association study of four variants in KCNQ1 with type 2 diabetes mellitus and premature coronary artery disease in a Chinese population.

Authors:  Zhong Chen; Xiaofeng Zhang; Genshan Ma; Qi Qian; Yuyu Yao
Journal:  Mol Biol Rep       Date:  2009-07-03       Impact factor: 2.316

Review 8.  Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis.

Authors:  Y G Kim; S Hahn; T J Oh; S H Kwak; K S Park; Y M Cho
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

9.  Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.

Authors:  Yasuharu Tabara; Haruhiko Osawa; Ryuichi Kawamoto; Hiroshi Onuma; Ikki Shimizu; Tetsuro Miki; Katsuhiko Kohara; Hideichi Makino
Journal:  Diabetes       Date:  2008-11-25       Impact factor: 9.461

10.  BMI and diabetes risk in Singaporean Chinese.

Authors:  Andrew O Odegaard; Woon-Puay Koh; Gabrielle Vazquez; Kazuko Arakawa; Hin-Peng Lee; Mimi C Yu; Mark A Pereira
Journal:  Diabetes Care       Date:  2009-03-26       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.